Related Experiment Video

Updated: Jun 28, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction

Mikhail Kosiborod1

  • 1Mid America Heart Institute of Saint Luke's Hospital, Kansas City, MO 64111, USA. mkosiborod@cc-pc.com

Diabetes & Vascular Disease Research
|October 30, 2008
PubMed

Insights

Hyperglycemia, or high blood sugar, in acute myocardial infarction (AMI) patients is linked to poor outcomes. This review examines current data and ongoing debates regarding this association.

Area of Science:

  • Cardiology
  • Endocrinology
  • Epidemiology

Background:

  • Elevated blood glucose is a known risk factor for cardiovascular events.
  • The relationship between hyperglycemia and outcomes in acute myocardial infarction (AMI) patients has been studied for decades.
  • Despite extensive research, significant questions and debates persist regarding this association.

Purpose of the Study:

  • To review current epidemiological data on hyperglycemia prevalence in AMI patients.
  • To analyze the relationship between hyperglycemia and patient outcomes following AMI.
  • To address and clarify existing controversies in the field.

Main Methods:

  • Systematic review of observational studies.
  • Analysis of epidemiological data on hyperglycemia in AMI.
  • Synthesis of evidence on the association between blood glucose levels and AMI outcomes.

Main Results:

  • Hyperglycemia is prevalent in AMI patients.
  • Elevated blood glucose levels are associated with adverse outcomes in AMI.
  • Existing controversies include the definition of hyperglycemia and its causal role.

Conclusions:

  • Hyperglycemia remains a significant concern in AMI management.
  • Further research is needed to resolve ongoing debates and refine treatment strategies.
  • Understanding this link is crucial for improving patient prognosis after AMI.

More Related Videos

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...